Chronic lymphocytic leukemia/small lymphocytic lymphoma

Chronic lymphocytic leukemia/small lymphocytic lymphoma. Clinical recommendations

Gespeichert in:

Autor*in:	E. A. Nikitin [verfasserIn] T. E. Bialik [verfasserIn] A. Iu. Zaritskii [verfasserIn] L. Iseber [verfasserIn] K. D. Kaplanov [verfasserIn] T. N. Lopatkina [verfasserIn] S. A. Lugovskaia [verfasserIn] O. V. Mukhortova [verfasserIn] E. A. Osmanov [verfasserIn] I. V. Poddubnaya [verfasserIn] O. S. Samoilova [verfasserIn] E. A. Stadnik [verfasserIn] N. A. Falaleeva [verfasserIn] V. V. Baikov [verfasserIn] A. M. Kovrigina [verfasserIn] A. A. Nevol’skikh [verfasserIn] S. A. Ivanov [verfasserIn] Zh. V. Khailova [verfasserIn] T. G. Gevorkian [verfasserIn]

Format:	E-Artikel
Sprache:	Russisch

Erschienen:	2020

Schlagwörter:	chronic lymphocytic leukemia small lymphocyte lymphoma immunochemotherapy targeted therapy 1st line therapy 2nd line therapy

Übergeordnetes Werk:	In: Современная онкология - IP Habib O.N., 2019, 22(2020), 3, Seite 24-44
Übergeordnetes Werk:	volume:22 ; year:2020 ; number:3 ; pages:24-44

Links:	Link aufrufen Link aufrufen Link aufrufen Journal toc Journal toc

DOI / URN:	10.26442/18151434.2020.3.200385

Katalog-ID:	DOAJ075636646

Internformat


LEADER	01000caa a22002652 4500
001	DOAJ075636646
003	DE-627
005	20230309134947.0
007	cr uuu---uuuuu
008	230228s2020 xx \|\|\|\|\|o 00\| \|\|rus c
024	7		\|a 10.26442/18151434.2020.3.200385 \|2 doi
035			\|a (DE-627)DOAJ075636646
035			\|a (DE-599)DOAJ0f3917e46f764e658e649fc6cb727659
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a rus
050		0	\|a RC254-282
100	0		\|a E. A. Nikitin \|e verfasserin \|4 aut
245	1	0	\|a Chronic lymphocytic leukemia/small lymphocytic lymphoma
264		1	\|c 2020
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
520			\|a Chronic lymphocytic leukemia/small lymphocytic lymphoma. Clinical recommendations
650		4	\|a chronic lymphocytic leukemia
650		4	\|a small lymphocyte lymphoma
650		4	\|a immunochemotherapy
650		4	\|a targeted therapy
650		4	\|a 1st line therapy
650		4	\|a 2nd line therapy
653		0	\|a Neoplasms. Tumors. Oncology. Including cancer and carcinogens
700	0		\|a T. E. Bialik \|e verfasserin \|4 aut
700	0		\|a A. Iu. Zaritskii \|e verfasserin \|4 aut
700	0		\|a L. Iseber \|e verfasserin \|4 aut
700	0		\|a K. D. Kaplanov \|e verfasserin \|4 aut
700	0		\|a T. N. Lopatkina \|e verfasserin \|4 aut
700	0		\|a S. A. Lugovskaia \|e verfasserin \|4 aut
700	0		\|a O. V. Mukhortova \|e verfasserin \|4 aut
700	0		\|a E. A. Osmanov \|e verfasserin \|4 aut
700	0		\|a I. V. Poddubnaya \|e verfasserin \|4 aut
700	0		\|a O. S. Samoilova \|e verfasserin \|4 aut
700	0		\|a E. A. Stadnik \|e verfasserin \|4 aut
700	0		\|a N. A. Falaleeva \|e verfasserin \|4 aut
700	0		\|a V. V. Baikov \|e verfasserin \|4 aut
700	0		\|a A. M. Kovrigina \|e verfasserin \|4 aut
700	0		\|a A. A. Nevol’skikh \|e verfasserin \|4 aut
700	0		\|a S. A. Ivanov \|e verfasserin \|4 aut
700	0		\|a Zh. V. Khailova \|e verfasserin \|4 aut
700	0		\|a T. G. Gevorkian \|e verfasserin \|4 aut
773	0	8	\|i In \|t Современная онкология \|d IP Habib O.N., 2019 \|g 22(2020), 3, Seite 24-44 \|w (DE-627)1760605514 \|x 18151442 \|7 nnns
773	1	8	\|g volume:22 \|g year:2020 \|g number:3 \|g pages:24-44
856	4	0	\|u https://doi.org/10.26442/18151434.2020.3.200385 \|z kostenfrei
856	4	0	\|u https://doaj.org/article/0f3917e46f764e658e649fc6cb727659 \|z kostenfrei
856	4	0	\|u https://modernonco.orscience.ru/1815-1434/article/viewFile/52480/35932 \|z kostenfrei
856	4	2	\|u https://doaj.org/toc/1815-1434 \|y Journal toc \|z kostenfrei
856	4	2	\|u https://doaj.org/toc/1815-1442 \|y Journal toc \|z kostenfrei
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_DOAJ
951			\|a AR
952			\|d 22 \|j 2020 \|e 3 \|h 24-44

Indexfelder

author_variant	e a n ean t e b teb a i z aiz l i li k d k kdk t n l tnl s a l sal o v m ovm e a o eao i v p ivp o s s oss e a s eas n a f naf v v b vvb a m k amk a a n aan s a i sai z v k zvk t g g tgg
matchkey_str	article:18151442:2020----::hoilmhctcekmamllmh
hierarchy_sort_str	2020
callnumber-subject-code	RC
publishDate	2020
allfields	10.26442/18151434.2020.3.200385 doi (DE-627)DOAJ075636646 (DE-599)DOAJ0f3917e46f764e658e649fc6cb727659 DE-627 ger DE-627 rakwb rus RC254-282 E. A. Nikitin verfasserin aut Chronic lymphocytic leukemia/small lymphocytic lymphoma 2020 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Chronic lymphocytic leukemia/small lymphocytic lymphoma. Clinical recommendations chronic lymphocytic leukemia small lymphocyte lymphoma immunochemotherapy targeted therapy 1st line therapy 2nd line therapy Neoplasms. Tumors. Oncology. Including cancer and carcinogens T. E. Bialik verfasserin aut A. Iu. Zaritskii verfasserin aut L. Iseber verfasserin aut K. D. Kaplanov verfasserin aut T. N. Lopatkina verfasserin aut S. A. Lugovskaia verfasserin aut O. V. Mukhortova verfasserin aut E. A. Osmanov verfasserin aut I. V. Poddubnaya verfasserin aut O. S. Samoilova verfasserin aut E. A. Stadnik verfasserin aut N. A. Falaleeva verfasserin aut V. V. Baikov verfasserin aut A. M. Kovrigina verfasserin aut A. A. Nevol’skikh verfasserin aut S. A. Ivanov verfasserin aut Zh. V. Khailova verfasserin aut T. G. Gevorkian verfasserin aut In Современная онкология IP Habib O.N., 2019 22(2020), 3, Seite 24-44 (DE-627)1760605514 18151442 nnns volume:22 year:2020 number:3 pages:24-44 https://doi.org/10.26442/18151434.2020.3.200385 kostenfrei https://doaj.org/article/0f3917e46f764e658e649fc6cb727659 kostenfrei https://modernonco.orscience.ru/1815-1434/article/viewFile/52480/35932 kostenfrei https://doaj.org/toc/1815-1434 Journal toc kostenfrei https://doaj.org/toc/1815-1442 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 22 2020 3 24-44
spelling	10.26442/18151434.2020.3.200385 doi (DE-627)DOAJ075636646 (DE-599)DOAJ0f3917e46f764e658e649fc6cb727659 DE-627 ger DE-627 rakwb rus RC254-282 E. A. Nikitin verfasserin aut Chronic lymphocytic leukemia/small lymphocytic lymphoma 2020 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Chronic lymphocytic leukemia/small lymphocytic lymphoma. Clinical recommendations chronic lymphocytic leukemia small lymphocyte lymphoma immunochemotherapy targeted therapy 1st line therapy 2nd line therapy Neoplasms. Tumors. Oncology. Including cancer and carcinogens T. E. Bialik verfasserin aut A. Iu. Zaritskii verfasserin aut L. Iseber verfasserin aut K. D. Kaplanov verfasserin aut T. N. Lopatkina verfasserin aut S. A. Lugovskaia verfasserin aut O. V. Mukhortova verfasserin aut E. A. Osmanov verfasserin aut I. V. Poddubnaya verfasserin aut O. S. Samoilova verfasserin aut E. A. Stadnik verfasserin aut N. A. Falaleeva verfasserin aut V. V. Baikov verfasserin aut A. M. Kovrigina verfasserin aut A. A. Nevol’skikh verfasserin aut S. A. Ivanov verfasserin aut Zh. V. Khailova verfasserin aut T. G. Gevorkian verfasserin aut In Современная онкология IP Habib O.N., 2019 22(2020), 3, Seite 24-44 (DE-627)1760605514 18151442 nnns volume:22 year:2020 number:3 pages:24-44 https://doi.org/10.26442/18151434.2020.3.200385 kostenfrei https://doaj.org/article/0f3917e46f764e658e649fc6cb727659 kostenfrei https://modernonco.orscience.ru/1815-1434/article/viewFile/52480/35932 kostenfrei https://doaj.org/toc/1815-1434 Journal toc kostenfrei https://doaj.org/toc/1815-1442 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 22 2020 3 24-44
allfields_unstemmed	10.26442/18151434.2020.3.200385 doi (DE-627)DOAJ075636646 (DE-599)DOAJ0f3917e46f764e658e649fc6cb727659 DE-627 ger DE-627 rakwb rus RC254-282 E. A. Nikitin verfasserin aut Chronic lymphocytic leukemia/small lymphocytic lymphoma 2020 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Chronic lymphocytic leukemia/small lymphocytic lymphoma. Clinical recommendations chronic lymphocytic leukemia small lymphocyte lymphoma immunochemotherapy targeted therapy 1st line therapy 2nd line therapy Neoplasms. Tumors. Oncology. Including cancer and carcinogens T. E. Bialik verfasserin aut A. Iu. Zaritskii verfasserin aut L. Iseber verfasserin aut K. D. Kaplanov verfasserin aut T. N. Lopatkina verfasserin aut S. A. Lugovskaia verfasserin aut O. V. Mukhortova verfasserin aut E. A. Osmanov verfasserin aut I. V. Poddubnaya verfasserin aut O. S. Samoilova verfasserin aut E. A. Stadnik verfasserin aut N. A. Falaleeva verfasserin aut V. V. Baikov verfasserin aut A. M. Kovrigina verfasserin aut A. A. Nevol’skikh verfasserin aut S. A. Ivanov verfasserin aut Zh. V. Khailova verfasserin aut T. G. Gevorkian verfasserin aut In Современная онкология IP Habib O.N., 2019 22(2020), 3, Seite 24-44 (DE-627)1760605514 18151442 nnns volume:22 year:2020 number:3 pages:24-44 https://doi.org/10.26442/18151434.2020.3.200385 kostenfrei https://doaj.org/article/0f3917e46f764e658e649fc6cb727659 kostenfrei https://modernonco.orscience.ru/1815-1434/article/viewFile/52480/35932 kostenfrei https://doaj.org/toc/1815-1434 Journal toc kostenfrei https://doaj.org/toc/1815-1442 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 22 2020 3 24-44
allfieldsGer	10.26442/18151434.2020.3.200385 doi (DE-627)DOAJ075636646 (DE-599)DOAJ0f3917e46f764e658e649fc6cb727659 DE-627 ger DE-627 rakwb rus RC254-282 E. A. Nikitin verfasserin aut Chronic lymphocytic leukemia/small lymphocytic lymphoma 2020 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Chronic lymphocytic leukemia/small lymphocytic lymphoma. Clinical recommendations chronic lymphocytic leukemia small lymphocyte lymphoma immunochemotherapy targeted therapy 1st line therapy 2nd line therapy Neoplasms. Tumors. Oncology. Including cancer and carcinogens T. E. Bialik verfasserin aut A. Iu. Zaritskii verfasserin aut L. Iseber verfasserin aut K. D. Kaplanov verfasserin aut T. N. Lopatkina verfasserin aut S. A. Lugovskaia verfasserin aut O. V. Mukhortova verfasserin aut E. A. Osmanov verfasserin aut I. V. Poddubnaya verfasserin aut O. S. Samoilova verfasserin aut E. A. Stadnik verfasserin aut N. A. Falaleeva verfasserin aut V. V. Baikov verfasserin aut A. M. Kovrigina verfasserin aut A. A. Nevol’skikh verfasserin aut S. A. Ivanov verfasserin aut Zh. V. Khailova verfasserin aut T. G. Gevorkian verfasserin aut In Современная онкология IP Habib O.N., 2019 22(2020), 3, Seite 24-44 (DE-627)1760605514 18151442 nnns volume:22 year:2020 number:3 pages:24-44 https://doi.org/10.26442/18151434.2020.3.200385 kostenfrei https://doaj.org/article/0f3917e46f764e658e649fc6cb727659 kostenfrei https://modernonco.orscience.ru/1815-1434/article/viewFile/52480/35932 kostenfrei https://doaj.org/toc/1815-1434 Journal toc kostenfrei https://doaj.org/toc/1815-1442 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 22 2020 3 24-44
allfieldsSound	10.26442/18151434.2020.3.200385 doi (DE-627)DOAJ075636646 (DE-599)DOAJ0f3917e46f764e658e649fc6cb727659 DE-627 ger DE-627 rakwb rus RC254-282 E. A. Nikitin verfasserin aut Chronic lymphocytic leukemia/small lymphocytic lymphoma 2020 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Chronic lymphocytic leukemia/small lymphocytic lymphoma. Clinical recommendations chronic lymphocytic leukemia small lymphocyte lymphoma immunochemotherapy targeted therapy 1st line therapy 2nd line therapy Neoplasms. Tumors. Oncology. Including cancer and carcinogens T. E. Bialik verfasserin aut A. Iu. Zaritskii verfasserin aut L. Iseber verfasserin aut K. D. Kaplanov verfasserin aut T. N. Lopatkina verfasserin aut S. A. Lugovskaia verfasserin aut O. V. Mukhortova verfasserin aut E. A. Osmanov verfasserin aut I. V. Poddubnaya verfasserin aut O. S. Samoilova verfasserin aut E. A. Stadnik verfasserin aut N. A. Falaleeva verfasserin aut V. V. Baikov verfasserin aut A. M. Kovrigina verfasserin aut A. A. Nevol’skikh verfasserin aut S. A. Ivanov verfasserin aut Zh. V. Khailova verfasserin aut T. G. Gevorkian verfasserin aut In Современная онкология IP Habib O.N., 2019 22(2020), 3, Seite 24-44 (DE-627)1760605514 18151442 nnns volume:22 year:2020 number:3 pages:24-44 https://doi.org/10.26442/18151434.2020.3.200385 kostenfrei https://doaj.org/article/0f3917e46f764e658e649fc6cb727659 kostenfrei https://modernonco.orscience.ru/1815-1434/article/viewFile/52480/35932 kostenfrei https://doaj.org/toc/1815-1434 Journal toc kostenfrei https://doaj.org/toc/1815-1442 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 22 2020 3 24-44
language	Russian
source	In Современная онкология 22(2020), 3, Seite 24-44 volume:22 year:2020 number:3 pages:24-44
sourceStr	In Современная онкология 22(2020), 3, Seite 24-44 volume:22 year:2020 number:3 pages:24-44
format_phy_str_mv	Article
institution	findex.gbv.de
topic_facet	chronic lymphocytic leukemia small lymphocyte lymphoma immunochemotherapy targeted therapy 1st line therapy 2nd line therapy Neoplasms. Tumors. Oncology. Including cancer and carcinogens
isfreeaccess_bool	true
container_title	Современная онкология
authorswithroles_txt_mv	E. A. Nikitin @@aut@@ T. E. Bialik @@aut@@ A. Iu. Zaritskii @@aut@@ L. Iseber @@aut@@ K. D. Kaplanov @@aut@@ T. N. Lopatkina @@aut@@ S. A. Lugovskaia @@aut@@ O. V. Mukhortova @@aut@@ E. A. Osmanov @@aut@@ I. V. Poddubnaya @@aut@@ O. S. Samoilova @@aut@@ E. A. Stadnik @@aut@@ N. A. Falaleeva @@aut@@ V. V. Baikov @@aut@@ A. M. Kovrigina @@aut@@ A. A. Nevol’skikh @@aut@@ S. A. Ivanov @@aut@@ Zh. V. Khailova @@aut@@ T. G. Gevorkian @@aut@@
publishDateDaySort_date	2020-01-01T00:00:00Z
hierarchy_top_id	1760605514
id	DOAJ075636646
language_de	russisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ075636646</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230309134947.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230228s2020 xx \|\|\|\|\|o 00\| \|\|rus c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.26442/18151434.2020.3.200385</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ075636646</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ0f3917e46f764e658e649fc6cb727659</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">rus</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC254-282</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">E. A. Nikitin</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Chronic lymphocytic leukemia/small lymphocytic lymphoma</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2020</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Chronic lymphocytic leukemia/small lymphocytic lymphoma. Clinical recommendations</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">chronic lymphocytic leukemia</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">small lymphocyte lymphoma</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">immunochemotherapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">targeted therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">1st line therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">2nd line therapy</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Neoplasms. Tumors. Oncology. Including cancer and carcinogens</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">T. E. Bialik</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">A. Iu. Zaritskii</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">L. Iseber</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">K. D. Kaplanov</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">T. N. Lopatkina</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">S. A. Lugovskaia</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">O. V. Mukhortova</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">E. A. Osmanov</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">I. V. Poddubnaya</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">O. S. Samoilova</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">E. A. Stadnik</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">N. A. Falaleeva</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">V. V. Baikov</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">A. M. Kovrigina</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">A. A. Nevol’skikh</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">S. A. Ivanov</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Zh. V. Khailova</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">T. G. Gevorkian</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Современная онкология</subfield><subfield code="d">IP Habib O.N., 2019</subfield><subfield code="g">22(2020), 3, Seite 24-44</subfield><subfield code="w">(DE-627)1760605514</subfield><subfield code="x">18151442</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:22</subfield><subfield code="g">year:2020</subfield><subfield code="g">number:3</subfield><subfield code="g">pages:24-44</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.26442/18151434.2020.3.200385</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/0f3917e46f764e658e649fc6cb727659</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://modernonco.orscience.ru/1815-1434/article/viewFile/52480/35932</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1815-1434</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1815-1442</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">22</subfield><subfield code="j">2020</subfield><subfield code="e">3</subfield><subfield code="h">24-44</subfield></datafield></record></collection>
callnumber-first	R - Medicine
author	E. A. Nikitin
spellingShingle	E. A. Nikitin misc RC254-282 misc chronic lymphocytic leukemia misc small lymphocyte lymphoma misc immunochemotherapy misc targeted therapy misc 1st line therapy misc 2nd line therapy misc Neoplasms. Tumors. Oncology. Including cancer and carcinogens Chronic lymphocytic leukemia/small lymphocytic lymphoma
authorStr	E. A. Nikitin
ppnlink_with_tag_str_mv	@@773@@(DE-627)1760605514
format	electronic Article
delete_txt_mv	keep
author_role	aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut
collection	DOAJ
remote_str	true
callnumber-label	RC254-282
illustrated	Not Illustrated
issn	18151442
topic_title	RC254-282 Chronic lymphocytic leukemia/small lymphocytic lymphoma chronic lymphocytic leukemia small lymphocyte lymphoma immunochemotherapy targeted therapy 1st line therapy 2nd line therapy
topic	misc RC254-282 misc chronic lymphocytic leukemia misc small lymphocyte lymphoma misc immunochemotherapy misc targeted therapy misc 1st line therapy misc 2nd line therapy misc Neoplasms. Tumors. Oncology. Including cancer and carcinogens
topic_unstemmed	misc RC254-282 misc chronic lymphocytic leukemia misc small lymphocyte lymphoma misc immunochemotherapy misc targeted therapy misc 1st line therapy misc 2nd line therapy misc Neoplasms. Tumors. Oncology. Including cancer and carcinogens
topic_browse	misc RC254-282 misc chronic lymphocytic leukemia misc small lymphocyte lymphoma misc immunochemotherapy misc targeted therapy misc 1st line therapy misc 2nd line therapy misc Neoplasms. Tumors. Oncology. Including cancer and carcinogens
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	cr
hierarchy_parent_title	Современная онкология
hierarchy_parent_id	1760605514
hierarchy_top_title	Современная онкология
isfreeaccess_txt	true
familylinks_str_mv	(DE-627)1760605514
title	Chronic lymphocytic leukemia/small lymphocytic lymphoma
ctrlnum	(DE-627)DOAJ075636646 (DE-599)DOAJ0f3917e46f764e658e649fc6cb727659
title_full	Chronic lymphocytic leukemia/small lymphocytic lymphoma
author_sort	E. A. Nikitin
journal	Современная онкология
journalStr	Современная онкология
callnumber-first-code	R
lang_code	rus
isOA_bool	true
recordtype	marc
publishDateSort	2020
contenttype_str_mv	txt
container_start_page	24
author_browse	E. A. Nikitin T. E. Bialik A. Iu. Zaritskii L. Iseber K. D. Kaplanov T. N. Lopatkina S. A. Lugovskaia O. V. Mukhortova E. A. Osmanov I. V. Poddubnaya O. S. Samoilova E. A. Stadnik N. A. Falaleeva V. V. Baikov A. M. Kovrigina A. A. Nevol’skikh S. A. Ivanov Zh. V. Khailova T. G. Gevorkian
container_volume	22
class	RC254-282
format_se	Elektronische Aufsätze
author-letter	E. A. Nikitin
doi_str_mv	10.26442/18151434.2020.3.200385
author2-role	verfasserin
title_sort	chronic lymphocytic leukemia/small lymphocytic lymphoma
callnumber	RC254-282
title_auth	Chronic lymphocytic leukemia/small lymphocytic lymphoma
abstract	Chronic lymphocytic leukemia/small lymphocytic lymphoma. Clinical recommendations
abstractGer	Chronic lymphocytic leukemia/small lymphocytic lymphoma. Clinical recommendations
abstract_unstemmed	Chronic lymphocytic leukemia/small lymphocytic lymphoma. Clinical recommendations
collection_details	GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ
container_issue	3
title_short	Chronic lymphocytic leukemia/small lymphocytic lymphoma
url	https://doi.org/10.26442/18151434.2020.3.200385 https://doaj.org/article/0f3917e46f764e658e649fc6cb727659 https://modernonco.orscience.ru/1815-1434/article/viewFile/52480/35932 https://doaj.org/toc/1815-1434 https://doaj.org/toc/1815-1442
remote_bool	true
author2	T. E. Bialik A. Iu. Zaritskii L. Iseber K. D. Kaplanov T. N. Lopatkina S. A. Lugovskaia O. V. Mukhortova E. A. Osmanov I. V. Poddubnaya O. S. Samoilova E. A. Stadnik N. A. Falaleeva V. V. Baikov A. M. Kovrigina A. A. Nevol’skikh S. A. Ivanov Zh. V. Khailova T. G. Gevorkian
author2Str	T. E. Bialik A. Iu. Zaritskii L. Iseber K. D. Kaplanov T. N. Lopatkina S. A. Lugovskaia O. V. Mukhortova E. A. Osmanov I. V. Poddubnaya O. S. Samoilova E. A. Stadnik N. A. Falaleeva V. V. Baikov A. M. Kovrigina A. A. Nevol’skikh S. A. Ivanov Zh. V. Khailova T. G. Gevorkian
ppnlink	1760605514
callnumber-subject	RC - Internal Medicine
mediatype_str_mv	c
isOA_txt	true
hochschulschrift_bool	false
doi_str	10.26442/18151434.2020.3.200385
callnumber-a	RC254-282
up_date	2024-07-03T16:00:53.807Z
_version_	1803574264527323136
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ075636646</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230309134947.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230228s2020 xx \|\|\|\|\|o 00\| \|\|rus c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.26442/18151434.2020.3.200385</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ075636646</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ0f3917e46f764e658e649fc6cb727659</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">rus</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC254-282</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">E. A. Nikitin</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Chronic lymphocytic leukemia/small lymphocytic lymphoma</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2020</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Chronic lymphocytic leukemia/small lymphocytic lymphoma. Clinical recommendations</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">chronic lymphocytic leukemia</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">small lymphocyte lymphoma</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">immunochemotherapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">targeted therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">1st line therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">2nd line therapy</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Neoplasms. Tumors. Oncology. Including cancer and carcinogens</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">T. E. Bialik</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">A. Iu. Zaritskii</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">L. Iseber</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">K. D. Kaplanov</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">T. N. Lopatkina</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">S. A. Lugovskaia</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">O. V. Mukhortova</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">E. A. Osmanov</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">I. V. Poddubnaya</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">O. S. Samoilova</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">E. A. Stadnik</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">N. A. Falaleeva</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">V. V. Baikov</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">A. M. Kovrigina</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">A. A. Nevol’skikh</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">S. A. Ivanov</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Zh. V. Khailova</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">T. G. Gevorkian</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Современная онкология</subfield><subfield code="d">IP Habib O.N., 2019</subfield><subfield code="g">22(2020), 3, Seite 24-44</subfield><subfield code="w">(DE-627)1760605514</subfield><subfield code="x">18151442</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:22</subfield><subfield code="g">year:2020</subfield><subfield code="g">number:3</subfield><subfield code="g">pages:24-44</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.26442/18151434.2020.3.200385</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/0f3917e46f764e658e649fc6cb727659</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://modernonco.orscience.ru/1815-1434/article/viewFile/52480/35932</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1815-1434</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1815-1442</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">22</subfield><subfield code="j">2020</subfield><subfield code="e">3</subfield><subfield code="h">24-44</subfield></datafield></record></collection>
score	7.401865

Nicht das Richtige dabei?

Schreiben Sie uns!

Chronic lymphocytic leukemia/small lymphocytic lymphoma

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?